Aster DM Quality Care subsidiary gets ICRA rating upgrade

KIMS Healthcare Management Limited’s long-term ratings upgraded from ICRA AA- to ICRA AA Stable.

FY2026 operating income reached ₹1,553.6 crore, up from ₹1,264.8 crore in FY2025.

Reader Takeaway: Stronger finances improve credit profile, but concentration risk remains.

What just happened

ICRA Limited upgraded the credit ratings of KIMS Healthcare Management Limited (KHML), a material subsidiary of Aster DM Quality Care Limited. The ratings were removed from Rating Watch with Developing Implications and assigned a Stable outlook.

The upgrade applies to KHML’s long-term fund-based cash credit and term loan facilities, while short-term fund-based ratings were reaffirmed at ICRA A1+.

Why this matters

The rating action reflects improvement in the group’s business and financial risk profile following Aster DM Quality Care’s merger with Quality Care India Limited.

ICRA said KHML benefits from its strategic importance within the parent group, established brand presence and expected operational synergies from the larger healthcare platform.

KHML reported revenue growth of 23% in FY2026, supported by higher patient volumes and pricing improvements. Operating margins expanded to 30.2% from 26.2% in the previous year.

Interest coverage improved to 23.4 times in FY2026 from 18.7 times, indicating stronger debt servicing ability.

The backstory

KHML operates healthcare facilities with a significant presence in Kerala and Tamil Nadu. The company’s performance has improved as the larger Aster DM Quality Care platform integrates operations and expands scale.

The FY2026 consolidated operating income increased to ₹1,553.6 crore, while adjusted profit after tax stood at ₹233.9 crore after accounting for a one-time expense related to the stake sale of GCC operations.

Risks to watch

ICRA highlighted geographic concentration as a key monitoring factor. KHML’s Trivandrum facility contributed around 70% of operating income and 77% of OPBDIT in FY2026.

The company also faces competition in healthcare markets and potential regulatory changes related to pricing policies.

What to track next

Investors will watch whether KHML can diversify revenue beyond its largest facility, execute planned capacity additions and maintain the improved profitability levels after integration with the parent group.